亞瑟斯抑制素A品管液:\nQC1:Recombinant human inhibin A at a level of approximately 150 pg/mL, buffered BSA matrix, <0.1% sodium azide, and 0.5% ProClin 300.\nQC2:Recombinant human inhibin A at a level of approximately 400 pg/mL, buffered BSA matrix, <0.1% sodium azide, and 0.5% ProClin 300.\nQC3:Recombinant human inhibin A at a level of approximately 800 pg/mL, buffered BSA matrix, <0.1% sodium azide, and 0.5% ProClin 300.\n

共有 1 個藥物證書使用此成份

申請商
美商貝克曼庫爾特有限公司台灣分公司 
適應症
含量
發證日期
2007-07-23